Quarterly report · Q2

Period2023-04-01 → 2023-09-30
Filed2023-11-09
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥3.9bn2023-04-01 → 2023-09-30Cons.Net sales
Revenue¥8.1bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥4.2bn2022-04-01 → 2022-09-30Cons.Net sales
Operating income¥247m2023-04-01 → 2023-09-30Cons.Operating income
Operating income¥373m2022-04-01 → 2022-09-30Cons.Operating income
Ordinary income¥240m2023-04-01 → 2023-09-30Cons.Ordinary income
Ordinary income¥730m2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥370m2022-04-01 → 2022-09-30Cons.Ordinary income
Profit before tax¥238m2023-04-01 → 2023-09-30Cons.Income before income taxes
Profit before tax¥362m2022-04-01 → 2022-09-30Cons.Income before income taxes
Net income (owners)¥174m2023-04-01 → 2023-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥517m2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥258m2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent
Net income¥174m2023-04-01 → 2023-09-30Cons.Profit loss
Net income¥258m2022-04-01 → 2022-09-30Cons.Profit loss
Total assets¥11.4bnat 2023-09-30Cons.Assets
Total assets¥11.5bnat 2023-03-31Cons.Assets
Total assets¥11.5bnat 2022-09-30Cons.Total assets (5-year summary)
Total liabilities¥7.7bnat 2023-09-30Cons.Liabilities
Total liabilities¥7.9bnat 2023-03-31Cons.Liabilities
Net assets / equity¥3.7bnat 2023-09-30Cons.Net assets
Net assets / equity¥3.6bnat 2023-03-31Cons.Net assets
Net assets / equity¥3.3bnat 2022-09-30Cons.Net assets (5-year summary)
Cash and deposits¥1.8bnat 2023-09-30Cons.Cash and deposits
Cash and deposits¥1.9bnat 2023-03-31Cons.Cash and deposits
Cash & equivalents¥1.4bnat 2023-09-30Cons.Cash and cash equivalents
Cash & equivalents¥1.6bnat 2023-03-31Cons.Cash and cash equivalents
Cash & equivalents¥1.5bnat 2022-09-30Cons.Cash and cash equivalents
Cash & equivalents¥1.6bnat 2022-03-31dCons.Cash and cash equivalents
Operating cash flow¥153m2023-04-01 → 2023-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥772m2022-04-01 → 2023-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥406m2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥53m2023-04-01 → 2023-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥76m2022-04-01 → 2023-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥24m2022-04-01 → 2022-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥283m2023-04-01 → 2023-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥676m2022-04-01 → 2023-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥516m2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥1372023-04-01 → 2023-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥87.022023-07-01 → 2023-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥407.892022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥203.312022-04-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥100.52022-07-01 → 2022-09-30dCons.Basic earnings loss per share (5-year summary)
Equity ratio32.6%at 2023-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio31.2%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio28.8%at 2022-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 26
SegmentItemPeriodValue
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-09-30−¥239m
jpcrp040300-q2r_E01109-000Medical Equipmentreportable segmentrevenue2023-04-01 → 2023-09-30¥1.2bn
jpcrp040300-q2r_E01109-000Medical Equipmentreportable segmentrevenue external2023-04-01 → 2023-09-30¥1.2bn
jpcrp040300-q2r_E01109-000Medical Equipmentreportable segmentsegment profit2023-04-01 → 2023-09-30−¥2m
jpcrp040300-q2r_E01109-000Precision Equipmentreportable segmentrevenue2023-04-01 → 2023-09-30¥2.1bn
jpcrp040300-q2r_E01109-000Precision Equipmentreportable segmentrevenue external2023-04-01 → 2023-09-30¥2.1bn
jpcrp040300-q2r_E01109-000Precision Equipmentreportable segmentsegment profit2023-04-01 → 2023-09-30¥459m
jpcrp040300-q2r_E01109-000SPreportable segmentrevenue2023-04-01 → 2023-09-30¥397m
jpcrp040300-q2r_E01109-000SPreportable segmentrevenue external2023-04-01 → 2023-09-30¥397m
jpcrp040300-q2r_E01109-000SPreportable segmentsegment profit2023-04-01 → 2023-09-30¥13m
—segment totalrevenue2023-04-01 → 2023-09-30¥3.9bn
—segment totalrevenue external2023-04-01 → 2023-09-30¥3.9bn
—segment totalsegment profit2023-04-01 → 2023-09-30¥486m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-09-30−¥230m
jpcrp040300-q2r_E01109-000Medical Equipmentreportable segmentrevenue2022-04-01 → 2022-09-30¥1.2bn
jpcrp040300-q2r_E01109-000Medical Equipmentreportable segmentrevenue external2022-04-01 → 2022-09-30¥1.2bn
jpcrp040300-q2r_E01109-000Medical Equipmentreportable segmentsegment profit2022-04-01 → 2022-09-30−¥55m
jpcrp040300-q2r_E01109-000Precision Equipmentreportable segmentrevenue2022-04-01 → 2022-09-30¥2.6bn
jpcrp040300-q2r_E01109-000Precision Equipmentreportable segmentrevenue external2022-04-01 → 2022-09-30¥2.6bn
jpcrp040300-q2r_E01109-000Precision Equipmentreportable segmentsegment profit2022-04-01 → 2022-09-30¥601m
jpcrp040300-q2r_E01109-000SPreportable segmentrevenue2022-04-01 → 2022-09-30¥194m
jpcrp040300-q2r_E01109-000SPreportable segmentrevenue external2022-04-01 → 2022-09-30¥194m
jpcrp040300-q2r_E01109-000SPreportable segmentsegment profit2022-04-01 → 2022-09-30¥11m
—segment totalrevenue2022-04-01 → 2022-09-30¥4.2bn
—segment totalrevenue external2022-04-01 → 2022-09-30¥4.2bn
—segment totalsegment profit2022-04-01 → 2022-09-30¥603m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 495
ItemContextValueUnit
Independent auditors report consolidated (text)FilingDateInstantText · Plus
Audit firm1 consolidatedFilingDateInstant
Original text (Japanese)仰星監査法人
Cpa1 audit firm1 consolidatedFilingDateInstant
Original text (Japanese)川﨑  浩
Cpa2 audit firm1 consolidatedFilingDateInstant
Original text (Japanese)新島 敏也
Number of submissionFilingDateInstant1
Net sales (5-year summary)Prior1YTDDuration4171072000JPY
Net sales (5-year summary)CurrentYTDDuration3866268000JPY
Net sales (5-year summary)Prior1YearDuration8085388000JPY
Ordinary income loss (5-year summary)Prior1YTDDuration369972000JPY
Ordinary income loss (5-year summary)CurrentYTDDuration239886000JPY
Ordinary income loss (5-year summary)Prior1YearDuration730006000JPY
Profit loss attributable to owners of parent (5-year summary)Prior1YTDDuration257878000JPY
Profit loss attributable to owners of parent (5-year summary)CurrentYTDDuration173738000JPY
Profit loss attributable to owners of parent (5-year summary)Prior1YearDuration517312000JPY
Comprehensive income (5-year summary)Prior1YTDDuration285609000JPY
Comprehensive income (5-year summary)CurrentYTDDuration212538000JPY
Comprehensive income (5-year summary)Prior1YearDuration542571000JPY
Net assets (5-year summary)Prior1QuarterInstant3320206000JPY
Net assets (5-year summary)CurrentQuarterInstant3725999000JPY
Net assets (5-year summary)Prior1YearInstant3576883000JPY
Total assets (5-year summary)Prior1QuarterInstant11522431000JPY
Total assets (5-year summary)CurrentQuarterInstant11427669000JPY
Total assets (5-year summary)Prior1YearInstant11474789000JPY
Basic earnings loss per share (5-year summary)Prior1YTDDuration203.31
Basic earnings loss per share (5-year summary)CurrentYTDDuration137.00
Basic earnings loss per share (5-year summary)Prior1YearDuration407.89
Diluted earnings per share (5-year summary)Prior1YTDDuration-
Diluted earnings per share (5-year summary)CurrentYTDDuration-
Diluted earnings per share (5-year summary)Prior1YearDuration-
Equity to asset ratio (5-year summary)Prior1QuarterInstant0.288
Equity to asset ratio (5-year summary)CurrentQuarterInstant0.326
Equity to asset ratio (5-year summary)Prior1YearInstant0.312
Net cash provided by used in operating activities (5-year summary)Prior1YTDDuration405779000JPY
Net cash provided by used in operating activities (5-year summary)CurrentYTDDuration152780000JPY
Net cash provided by used in operating activities (5-year summary)Prior1YearDuration771638000JPY
Net cash provided by used in investing activities (5-year summary)Prior1YTDDuration-23561000JPY
Net cash provided by used in investing activities (5-year summary)CurrentYTDDuration-53026000JPY
Net cash provided by used in investing activities (5-year summary)Prior1YearDuration-75521000JPY
Net cash provided by used in financing activities (5-year summary)Prior1YTDDuration-515827000JPY
Net cash provided by used in financing activities (5-year summary)CurrentYTDDuration-282560000JPY
Net cash provided by used in financing activities (5-year summary)Prior1YearDuration-675573000JPY
Cash and cash equivalents (5-year summary)Prior1QuarterInstant1463550000JPY
Cash and cash equivalents (5-year summary)CurrentQuarterInstant1438337000JPY
Cash and cash equivalents (5-year summary)Prior1YearInstant1608304000JPY
Basic earnings loss per share (5-year summary)Prior1QuarterDuration100.50
Basic earnings loss per share (5-year summary)CurrentQuarterDuration87.02
Number of issued shares as of fiscal year end issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember1286199
Number of issued shares as of filing date issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember1286199
Number of issued shares as of fiscal year end issued shares total number of shares etcFilingDateInstant1286199
Number of issued shares as of filing date issued shares total number of shares etcFilingDateInstant1286199

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-09-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-09-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-09-30pass